All lobbying filings
E3 STRATEGIC CONSULTING GROUP
E3 STRATEGIC CONSULTING GROUP filed a Q1 report for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION on April 16, 2025, reporting $50,000 in lobbying income.
Lobbying for PHARMACEUTICAL INDUSTRY LABOR MANAGEMENT ASSOCIATION · Association
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 16, 2025
Income
$50,000
What the client paid this registrant for the period.
Client based in
Virginia
Government bodies contacted
2
Lobbying activity
1
Prescription drug industry issues relating to domestic construction and maintenance, prescription drug pricing, supply chain issues, pharmacy benefit managers transparency issues, Intellectual property, and employment issues, generally; S. 1040, Drug Competition Enhancement Act; H.R.1492 - To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program;